Description

Tpi-287 is a high-purity, small molecule compound of significant interest in advanced pharmaceutical research and development. This compound is valued for its potential as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents. It is primarily utilized by research institutions and pharmaceutical companies engaged in drug discovery, particularly in oncology and neurological disease research. Tpi-287 CAS NO 849213-15-6 represents a critical building block for scientists developing next-generation treatments.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the multi-step synthesis of complex drug candidates and active pharmaceutical ingredients (APIs).
• Oncology Research: Used in preclinical and discovery-stage research for developing potential anti-cancer therapies and targeted agents.
• Neurological Disease Research: Employed in studies targeting neurodegenerative conditions, such as Alzheimer's disease, for therapeutic exploration.
• Biochemical Research: Functions as a standard or reference compound in assay development, mechanism of action studies, and high-throughput screening.
• Process Chemistry & Scale-up: Applied in route scouting, optimization, and pilot-scale production for new chemical entities (NCEs).
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting the global pharmaceutical pipeline from discovery to development.

Basic Information

Product Name	Tpi-287
CAS No.	849213-15-6
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	TPI-287; TPI 287; 849213-15-6; TPI287; (1S,2S,3R,4S,5R,8R,9S,10R,11S)-12-[(2R)-2-Aminopropyl]-11-(hydroxymethyl)-3,4,5,8,9,10,11,12-octahydro-2H-10,4a-(epiminoethano)-1,5:8,9-diepoxycyclodeca[b]furan-2-one; Abecma precursor; Idecabtagene vicleucel synthetic intermediate
EINECS	Contact for details

Quality Control

Our Tpi-287 is manufactured under strict quality management systems to ensure batch-to-batch consistency and reliability. Each lot undergoes comprehensive analytical testing, including identity confirmation, purity assay, and impurity profiling using advanced techniques such as HPLC, GC, and NMR. A Certificate of Analysis (COA) detailing all test results and specifications is provided with every shipment. We support compliance with cGMP guidelines for advanced intermediates used in pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.